Phase
Condition
Opioid Use Disorder
Stimulant Use Disorder
Treatment
[11C]OMAR
Clinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Able to provide informed consent
Male and female 18 years and older
DSM-5 diagnosis of opioid use disorder (for OUD group)
Physically healthy i.e., no clinically unstable medical conditions
Written informed consent and have capacity to consent and comply with studyprocedures
Exclusion
Exclusion Criteria:
Current neuro-psychiatric illness or severe systemic disease (opioid use disorder ispermitted in the OUD group).
Presence of ferromagnetic metal in the body or heart pacemaker
Have had exposure to ionizing radiation that in combination with the study tracerwould result in a cumulative exposure that exceeds recommended exposure limits
Are claustrophobic
Hematocrit values lower than 30
Study Design
Study Description
Connect with a study center
Connecticut Mental Health Center, Clinical Neuroscience Research Unit
New Haven, Connecticut 06519
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.